tk88 bet

Health insurance should cover new medicine for Hepatitis C patients

Health experts have called on the Health Ministry to add direct-acting antiviral Agents (DAAs) into list of drugs that public health insurance covers so patients with Hepatitis C are treated more effectively.
Health insurance should cover new medicine for Hepatitis C patients ảnh 1A hepatitis patient receives treatment at Bach Mai Hospital.(Photo: VNA)
Hanoi (VNS/VNA) -Health experts have called on the Health Ministry to add direct-actingantiviral Agents (DAAs) into list of drugs that public health insurance coversso patients with Hepatitis C are treated more effectively.

DAAs or new combinations of drugs directly target the hepatitis C virus indifferent ways to stop it making copies of itself. DAAs promise shortertreatment times, much higher cure rates and fewer side effects.

Assistance Professor Dr Do Duy Cuong, head of Infection Department under BachMai Hospital, spoke about the new medicine at a July 24 meeting marking WorldHepatitis Day (July 28).

Cuong said that currently, there were 50 types of DAAs and the cure ratereached up to 95 percent.

However, cost treatment using DAAs was high while public health insuranceparticipants did not have health insurance pay for the medicine, Cuong said,adding that 90 percent of patients with Hepatitis C could not receive DAAstreatment.

“The Health Ministry should speed up allowing the medicines to be circulated inVietnam and public health insurance should co-pay it with the health insurancefund and patients at a reasonable proportion,” he said.

Hepatitis C is a “silent killer” because it has no obvious symptoms but can beextremely dangerous and, in some cases, life threatening, according to theVietnam Association for the Study of Liver Diseases (VLBA).

The hepatitis C virus (HCV) can be transmitted by blood, tooth extraction andunprotected sex, and the number of infected people in the country isincreasing. In the early stages of the disease, most hepatitis C patients haveno symptoms and it does not affect their, so most people do not realise whenthey are infected, according to experts.

A patient’s health can be severely affected when HCV transitions to cirrhosisand liver cancer. Patients at this stage have anorexia, indigestion, swellingin the legs, muscle aches, cramps, numbness, itching, dizziness, fatigue andtrembling hands. Severe complications such as gastrointestinal bleeding, fluidretention in the abdomen and drowsiness can occur.

Assistance Professor Dr Nguyen Quoc Anh, Bach Mai Hospital director, said therewere about 10 million people carrying Hepatitis B and nearly 1 million peoplecarrying Hepatitis C in the country.

“About 10-15 percent of the population was infected with Hepatitis B. Thedisease can develop quickly, causing liver failure and liver cancer,” Quoc Anhsaid.

Despite the fact that there was Hepatitis B a vaccine, the disease was stillburdening both the health sector and patients because of life-long treatment,he said.-VNS/VNA
VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

𓂃 Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

ಞ Sharp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

⛄ Vietnam, France collaborate in vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|